FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28770211000001106: EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Feb 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89573901000001115 EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
89574001000001117 EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Is a Lysine 500mg tablets 30 tablet true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has AMP EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has specific active ingredient L-lysine hydrochloride true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lysine true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
EN-Lysine 500mg tablets (Ennogen Healthcare Ltd) 30 tablet Has basis of strength substance Lysine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start